David Givol

Medicine · Health Sciences

82h-index21.4kcitations296works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(100), Glycosylation and Glycoproteins Research(59), Cancer-related Molecular Pathways(44), Chemical Synthesis and Analysis(28), Fibroblast Growth Factor Research(22)

Publications296 total

Data from Reversible Dysfunction of Wild-Type p53 following Homeodomain-Interacting Protein Kinase-2 Knockdown
2023Open Access
Supplementary Table 1 from Reversible Dysfunction of Wild-Type p53 following Homeodomain-Interacting Protein Kinase-2 Knockdown
2023Open Access
Supplementary Table 1 from Reversible Dysfunction of Wild-Type p53 following Homeodomain-Interacting Protein Kinase-2 Knockdown
2023Open Access
Data from Reversible Dysfunction of Wild-Type p53 following Homeodomain-Interacting Protein Kinase-2 Knockdown
2023Open Access
(rearranged c-myc/repetitive DNA/transposable element/Kpn I famil:
2016
Modulation of c-kit expression in pancreatic adenocarcinoma: A novel stem cell marker responsible for the progression of the disease
Acta Histochemica·2013· 11 cited
LGR5 and Nanog identify stem cell signature of pancreas beta cells which initiate pancreatic cancer
Biochemical and Biophysical Research Communications·2013· 44 cited
Figure 1, [Gene expression patterns identified from...].
2013
Differential localization of LGR5 and Nanog in clusters of colon cancer stem cells
Acta Histochemica·2012· 15 cited
Localization of the stem cell markers LGR5 and Nanog in the normal and the cancerous human ovary and their inter-relationship
Acta Histochemica·2012· 25 cited
HIPK2 downregulates vimentin and inhibits breast cancer cell invasion
Cancer Biology & Therapy·2012· 34 citedOpen Access
p53 reactivation
Cell Cycle·2012· 28 citedOpen Access
Genome-wide analysis discloses reversal of the hypoxia-induced changes of gene expression in colon cancer cells by zinc supplementation
Oncotarget·2011· 29 citedOpen Access
Zinc supplementation augments <i>in vivo</i> antitumor effect of chemotherapy by restoring p53 function
International Journal of Cancer·2011· 54 citedOpen Access
Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs
Cell Cycle·2011· 117 citedOpen Access
Zinc Downregulates HIF-1α and Inhibits Its Activity in Tumor Cells In Vitro and In Vivo
PLoS ONE·2010· 114 citedOpen Access
Counteracting MDM2‐induced HIPK2 downregulation restores HIPK2/p53 apoptotic signaling in cancer cells
FEBS Letters·2010· 12 citedOpen Access
Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells
Oncogene·2010· 137 cited
HIPK2--A therapeutical target to be (re)activated for tumor suppression: Role in p53 activation and HIF-1α inhibition
Cell Cycle·2010· 44 citedOpen Access
Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors
Biochemical and Biophysical Research Communications·2010· 236 cited
page 1 of 15Next →

Frequent Co-authors

Gideon Rechavi(9), Moshe Oren(6), Joseph Schlessinger(6), Avner Yayon(5), Ninette Amariglio(5), Eytan Domany(4), Peter Lonai(4), Yosef Yarden(4), Rina Zakut-Houri(4), Sima Lev(4), Itai Kela(3), Avi Orr‐Urtreger(3), Yitzhak Zimmer(3), Karuppiah Kannan(3), Hilah Gal(3), Giovanni Blandino(3), Irit Lax(3), R. Howk(3), Justus B. Cohen(3), Liat Ein‐Dor(2)